These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17391572)

  • 1. Biological markers as outcome measures for Alzheimer's disease interventions--real problems and future possibilities.
    Takeda M; Okochi M; Tagami S; Tanaka T; Kudo T
    Int Psychogeriatr; 2007 Jun; 19(3):391-400. PubMed ID: 17391572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Core biological marker candidates of Alzheimer's disease - perspectives for diagnosis, prediction of outcome and reflection of biological activity.
    Hampel H; Mitchell A; Blennow K; Frank RA; Brettschneider S; Weller L; Möller HJ
    J Neural Transm (Vienna); 2004 Mar; 111(3):247-72. PubMed ID: 14991453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease-modifying therapies for Alzheimer disease: challenges to early intervention.
    Cummings JL; Doody R; Clark C
    Neurology; 2007 Oct; 69(16):1622-34. PubMed ID: 17938373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020.
    Hampel H; Lista S; Teipel SJ; Garaci F; Nisticò R; Blennow K; Zetterberg H; Bertram L; Duyckaerts C; Bakardjian H; Drzezga A; Colliot O; Epelbaum S; Broich K; Lehéricy S; Brice A; Khachaturian ZS; Aisen PS; Dubois B
    Biochem Pharmacol; 2014 Apr; 88(4):426-49. PubMed ID: 24275164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic markers for diagnosis and pathogenesis of Alzheimer's disease.
    Kim DH; Yeo SH; Park JM; Choi JY; Lee TH; Park SY; Ock MS; Eo J; Kim HS; Cha HJ
    Gene; 2014 Jul; 545(2):185-93. PubMed ID: 24838203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers in Alzheimer's disease drug development.
    Cummings JL
    Alzheimers Dement; 2011 May; 7(3):e13-44. PubMed ID: 21550318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biomarkers of the Alzheimer's disease: concepts and clinical case].
    Bier JC
    Rev Med Brux; 2013 Sep; 34(4):306-10. PubMed ID: 24195245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers for preclinical Alzheimer's disease.
    Tan CC; Yu JT; Tan L
    J Alzheimers Dis; 2014; 42(4):1051-69. PubMed ID: 25024325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers in Alzheimer's disease: not yet surrogate endpoints.
    Coley N; Andrieu S; Delrieu J; Voisin T; Vellas B
    Ann N Y Acad Sci; 2009 Oct; 1180():119-24. PubMed ID: 19906266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future screening for incipient Alzheimer's disease--the influence of prevalence on test performance.
    Mattsson N; Zetterberg H
    Eur Neurol; 2009; 62(4):200-3. PubMed ID: 19602894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Early diagnosis of Alzheimer disease].
    Touchon J; Ritchie K; Gely-Nargeot MC
    Ann Med Interne (Paris); 1998 Jun; 149(4):193-201. PubMed ID: 11490546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease.
    Scheltens P; Blennow K; Breteler MM; de Strooper B; Frisoni GB; Salloway S; Van der Flier WM
    Lancet; 2016 Jul; 388(10043):505-17. PubMed ID: 26921134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health economic evaluation of treatments for Alzheimer's disease: impact of new diagnostic criteria.
    Wimo A; Ballard C; Brayne C; Gauthier S; Handels R; Jones RW; Jonsson L; Khachaturian AS; Kramberger M
    J Intern Med; 2014 Mar; 275(3):304-16. PubMed ID: 24605810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Early evaluation of Alzheimer's disease: biomarkers and neuropsychological tests].
    Lanfranco RG; Manríquez-Navarro P; Avello LG; Canales-Johnson A
    Rev Med Chil; 2012 Sep; 140(9):1191-200. PubMed ID: 23354643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of magnetic resonance imaging for early detection and diagnosis of Alzheimer disease.
    Teipel SJ; Grothe M; Lista S; Toschi N; Garaci FG; Hampel H
    Med Clin North Am; 2013 May; 97(3):399-424. PubMed ID: 23642578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspectives for multimodal neurochemical and imaging biomarkers in Alzheimer's disease.
    Teipel SJ; Sabri O; Grothe M; Barthel H; Prvulovic D; Buerger K; Bokde AL; Ewers M; Hoffmann W; Hampel H
    J Alzheimers Dis; 2013; 33 Suppl 1():S329-47. PubMed ID: 22735677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Near a biological diagnosis of Alzheimer's disease and related disorders].
    Krolak-Salmon P; Seguin J; Perret-Liaudet A; Desestret V; Vighetto A; Bonnefoy M
    Rev Med Interne; 2008 Oct; 29(10):785-93. PubMed ID: 18584921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging is superior to cognitive testing for early diagnosis of Alzheimer's disease.
    Zamrini E; De Santi S; Tolar M
    Neurobiol Aging; 2004; 25(5):685-91. PubMed ID: 15172748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detecting dementia: novel neuropsychological markers of preclinical Alzheimer's disease.
    Blackwell AD; Sahakian BJ; Vesey R; Semple JM; Robbins TW; Hodges JR
    Dement Geriatr Cogn Disord; 2004; 17(1-2):42-8. PubMed ID: 14560064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.